Compare VVOS & SEED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VVOS | SEED |
|---|---|---|
| Founded | 2016 | 1997 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.1M | 12.6M |
| IPO Year | 2020 | 2005 |
| Metric | VVOS | SEED |
|---|---|---|
| Price | $1.28 | $1.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.25 | N/A |
| AVG Volume (30 Days) | 88.8K | ★ 101.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.07 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,031,000.00 | N/A |
| Revenue This Year | $31.42 | N/A |
| Revenue Next Year | $49.82 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.91 | N/A |
| 52 Week Low | $1.28 | $0.82 |
| 52 Week High | $7.40 | $2.49 |
| Indicator | VVOS | SEED |
|---|---|---|
| Relative Strength Index (RSI) | 32.01 | 58.31 |
| Support Level | N/A | $0.96 |
| Resistance Level | $1.88 | $1.30 |
| Average True Range (ATR) | 0.12 | 0.13 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 6.25 | 57.43 |
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement. The company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.